Dysregulated expression of STAT1, miR‐150, and miR‐223 in peripheral blood mononuclear cells of coronary artery disease patients with significant or insignificant stenosis

Abstract

Coronary artery disease (CAD) is a multicellular disease characterized by chronic inflammation. Peripheral blood-mononuclear cells (PBMCs), as a critical component of immune system, actively cross-talk with pathophysiological conditions induced by endothelial cell injury, reflecting in perturbed PBMC expression. STAT1 is believed to be relevant to CAD pathogenesis through regulating key inflammatory processes and modulating STAT1 expression play key roles in fine-tuning CAD-related inflammatory processes. This study evaluated PBMC expressions of STAT1, and its regulators (miR-150 and miR-223) in a cohort including 72 patients with CAD with significant ( ≥ 50%) stenosis, 30 patients with insignificant ( < 50%) coronary stenosis (ICAD), and 74 healthy controls, and assessed potential of PBMC expressions to discriminate between patients and controls. We designed quantitative real-time polymerase chain reaction (RT-qPCR) assays and identified stable reference genes for normalizing PBMC quantities of miR-150, miR-223, and STAT1 applying geNorm algorithm to six small RNAs and five mRNAs. There was no significant difference between CAD and ICAD patients regarding STAT1 expression. However, both groups of patients had higher levels of STAT1 than healthy controls. miR-150 and miR-223 were differently expressed across three groups of subjects and were downregulated in patients compared with healthy controls, with the lowest expression levels being observed in patients with ICAD. ROC curves suggested that PBMC expressions may separate between different groups of study subjects. PBMC expressions also discriminated different clinical manifestations of CAD from ICADs or healthy controls. In conclusion, the present study reported PBMC dysregulations of STAT1, miR-150, and miR-223, in patients with significant or insignificant coronary stenosis and suggested that these changes may have diagnostic implications. K E Y W O R D Scoronary artery disease, microRNA, miR-150, miR-223, PBMC, peripheral blood mononuclear cell, STAT1

Down-regulated gga-miR-223 inhibits proliferation and induces apoptosis of MG-infected DF-1 cells by targeting FOXO3

“…Previous high-throughput sequencing data showed that gga-miR-223 was signally down-regulated in MG-infected chicken embryo lung [37]. Importantly, accumulating data has suggested that miR-223 plays an important role in various diseases, especially respiratory disease [20,38,39]. MiR-223 plays a key role in regulating the immune in ammatory response to neutrophil asthma by inhibiting the NLRP3/ IL-1β [40]; pharmacological blockade of the miR-223-NLRP3-IL-1β signaling axis alleviates acute respiratory distress syndrome [41].…”

Effects of hypothermia and pentoxifylline on the adnexal torsion/detorsion injuries in a rat testis model

“…Finally, a 260/280 ratio of 2.0 and 260/230 in the range of 2.0–2.2 was chosen as pure for RNA. For integrity evaluation of the samples, we used %1.5 agarose gel electrophoresis (Rodrigues & de Brito Neto, 2017; Saadatian et al., 2019). Total RNA (> 500 ng) was converted to cDNA using the cDNA Synthesis Kit (Cat No: YT4500; Yekta Tajhiz Azma®, Iran).…”

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target

“…More researches are needed to confirm the role of miR-223-3p as a diagnostic or predictive biomarker of myocardial infarction. Furthermore, the expression of miR-223-3p in peripheral blood mononuclear cells was downregulated in patients who were diagnosed as coronary artery disease with significant or insignificant stenosis compared with healthy controls, which was most prominent in patients with insignificant stenosis, indicating that miR-223-3p in peripheral blood mononuclear cells might be positively related to severity of coronary artery disease and could be used for discriminate patients with significant or insignificant stenosis (115).…”